Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:592-597
Published online before print January 26, 2004, doi: 10.1161/01.HYP.0000116224.51189.80
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/3/592    most recent
01.HYP.0000116224.51189.80v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Wowern, F.
Right arrow Articles by Melander, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Wowern, F.
Right arrow Articles by Melander, O.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Genetics of cardiovascular disease
Right arrow Functional genomics
Right arrow Genomics
Right arrow Hypertension - basic studies

(Hypertension. 2004;43:592.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension

Fredrik von Wowern; Kristina Bengtsson; Ulf Lindblad; Lennart Råstam; Olle Melander

From the Departments of Endocrinology (F.v.W., K.B., O.M.) and Community Medicine (K.B., U.L., L.R.), Malmö University Hospital, Malmö, Sweden.

Correspondence to Fredrik von Wowern, Department of Endocrinology, Wallenberg Laboratory, Ent 46, floor 3, Malmö University Hospital, SE-205 02 Malmö, Sweden. E-mail fredrik.wowern{at}endo.mas.lu.se

In a genome-wide scan in Scandinavians, we found suggestive linkage between early-onset primary hypertension and a region on chromosome 2. The {alpha}2B-adrenoceptor gene, a candidate gene within this region, harbors a functional insertion/deletion (I/D) polymorphism of three glutamate residues. The aim of this study was to investigate if the DD genotype is associated with hypertension in Swedes. We performed an association study between the I/D polymorphism of the {alpha}2B-adrenoceptor and hypertension in the Skaraborg population. The material consists of all known patients with primary hypertension in Skara (n=772 nondiabetic subjects; n=171 normoalbuminuric type 2 diabetic subjects) and 817 population control subjects. We first compared genotype frequencies between patients with early-onset hypertension (aged 50 years or younger at onset) and subjects with normotension (blood pressure <120/80 mm Hg). Thereafter, the polymorphism was tested for association with hypertension at the population level. When comparing patients with early-onset hypertension and normotensive subjects, the DD versus II genotype was associated with early-onset hypertension when diabetic subjects were excluded from the analysis (OR=2.0; 95% CI=1.2 to 3.5) or when they were not excluded (OR=1.8; 95% CI=1.0 to 3.1). At the population level, the DD versus II genotype was weakly associated with nondiabetic hypertension (OR=1.4; 95% CI=1.0 to 1.8). Our data suggest that carriers of the DD versus II genotype of the {alpha}2B-adrenoceptor are at increased risk for hypertension. The genotypic effect is most evident when comparing groups corresponding to the upper and lower tails of the blood pressure distribution in the population; however, in nondiabetic hypertensive subjects it is weakly detectable even at the population level.


Key Words: receptors • adrenergic • genetics • hypertension




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Duling, T. W. Cherng, J. R. Griego, M. F. Perrine, and N. L. Kanagy
Loss of {alpha}2B-adrenoceptors increases magnitude of hypertension following nitric oxide synthase inhibition
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2403 - H2408.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Kalmyrzaev, A. Aldashev, M. Khalmatov, A. Polupanov, A. Jumagulova, L. Mamanova, M. R. Wilkins, and M. Town
Genome-Wide Scan for Premature Hypertension Supports Linkage to Chromosome 2 in a Large Kyrgyz Family
Hypertension, November 1, 2006; 48(5): 908 - 913.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. P. Etzel, B. K. Rana, G. Wen, R. J. Parmer, N. J. Schork, D. T. O'Connor, and P. A. Insel
Genetic Variation at the Human {alpha}2B-Adrenergic Receptor Locus: Role in Blood Pressure Variation and Yohimbine Response
Hypertension, June 1, 2005; 45(6): 1207 - 1213.
[Abstract] [Full Text] [PDF]